A Phase I Clinical Trial of AK115 in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This trial is a randomized, double-blind, placebo-controlled dose escalation phase I trial following single dose subcutaneous administration of AK115 injection. It aims to evaluate the safety, pharmacokinetic characteristics, pharmacodynamic effect and immunogenicity of single dose of AK115 injection in healthy subjects.
Epistemonikos ID: 80cc3fbbc6ad725d8e0fdba1ad9f5342600d594d
First added on: May 10, 2024